跳至主要内容
临床试验/JPRN-jRCTs032220491
JPRN-jRCTs032220491已完成Unknown

An exploratory study on the effectiveness, usefulness, and safety of dietary management apps (Glucose Flight) in adult type 2 diabetic patients receiving insulin treatment

Ishii Hideto0 个研究点目标入组 8 人开始时间: 2022年12月7日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1) Patients who are using insulin in the diagnosis of type 2 diabetes
  • 2) Patients with HbA1c >=7.0% and <=10.0% at -8 weeks (retrospective data)
  • 3) Body Mass Index (BMI): Patients with BMI of more than 18.5 kg/m2 and less than 35.0 kg/m2
  • 4) Age at the time of obtaining consent: Patients over 20 years of age
  • 5) Gender: Regardless
  • 6) Patients for whom written consent has been obtained to participate in this study by their own free will

排除标准

  • 1) Patients with type 1 diabetes
  • 2) Patients with steroid diabetes
  • 3) Pregnant patients
  • 4) Patients with diabetic nephropathy Stage 3-5
  • 5) Patients currently diagnosed with cancer and undergoing treatment
  • 6) Patients with hemoglobin less than 11.0 g/dL within 1 year before informed consent
  • 7) Patients who received a blood transfusion within one month
  • 8) Patients who plan to receive blood transfusions during clinical trials
  • 9) Furthermore, patients whose participation in this study is inappropriate by the principal or sub investigator

研究者

发起方
Ishii Hideto

相似试验

进行中(未招募)
1 期
Reseach study that will evaluate the efficacy and safety of Bilastine in reducing itching in patients with chronic spontaneous urticaria and other skin diseases.Chronic spontaneous urticaria and the following skin disorders:1 - Eczema/dermatitis (acute eczema, chronic eczema, contact dermatitis, atopic dermatitis, nummular eczema, autosensitisation dermatitis, dyshidrotic eczema, asteatotic eczema, lichen simplex chronicus).2 - Prurigo (acute prurigo, subacute prurigo, chronic prurigo).3 - Cutaneous pruritus (systemic cutaneous pruritus, local cutaneous pruritus).MedDRA version: 19.0Level: HLTClassification code 10012435Term: Dermatitis and eczemaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 19.0Level: PTClassification code 10037083Term: PrurigoSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 19.0Level: PTClassification code 10052568Term: Urticaria chronicSystem Organ Class: 10040785 - Skin and subcutaneous tissue disorders
EUCTR2016-001505-17-ESFAES FARMA, S.A.115
进行中(未招募)
1 期
Reseach study that will evaluate the efficacy and safety of Bilastine in reducing itching in patients with chronic spontaneous urticaria and other skin diseases.
EUCTR2016-001505-17-HUFAES FARMA, S.A.115
尚未招募
1 期
Exploratory Research on the Efficacy Evaluation of Electroacupuncture in the Treatment of Cerebral Apoplexy and Paralysis Stage Based on the Theory of Treating Flaccid Paralysis by Yangming AStroke
ITMCTR2100005445Huashan Hospital,Fudan University
已完成
不适用
Examination of the effectiveness of Quasi-particle accelerator (QPA) for fibromyalgiafibromyalgia
JPRN-UMIN000044620Tokushima University3
进行中(未招募)
1 期
The exploratory study of EFE in COVID-19 patientsCOVID-19
JPRN-jRCT2031210063Odaguchi Hiroshi156